← Back to work
Works cited by this work
56 works
Work: <i>FLT3</i> -mutated AML: immune evasion through exosome-mediated mechanisms and innovative combination therapies targeting immune escape
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
Qingfang Han, Wenjia Li, Kaishun Hu +4
Review article20227 citationsABIExosomes: key players in cancer and potential therapeutic strategy
Jie Dai, Yangzhou Su, Suye Zhong +7
Review article20204 citationsABIRNA Trafficking by Acute Myelogenous Leukemia Exosomes
Jianya Huan, Noah I. Hornick, Matthew J. Shurtleff +4
Article20123 citationsABIPD-1/PD-L1 pathway: current researches in cancer.
Yanyan Han, Dandan Liu, Lianhong Li
Article20203 citationsABIRole of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Review article20233 citationsABI<i>IDH1</i>and<i>IDH2</i>Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With<i>NPM1</i>Mutation Without<i>FLT3</i>Internal Tandem Duplication
Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik +11
Article20102 citationsABIAcute Myeloid Leukemia
Hartmut Döhner, Daniel J. Weisdorf, Clara D. Bloomfield
Review article20152 citationsABI